For the readers interested in the stock health of Gamida Cell Ltd. (GMDA). It is currently valued at $9.24. When the transactions were called off in the previous session, Stock hit the highs of $9.2393, after setting-off with the price of $9.21. Company’s stock value dipped to $8.37 during the trading on the day. When the trading was stopped its value was $8.45.
Recently in News on December 17, 2020, Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares. Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of a follow-on public offering of 8,125,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $65.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Gamida Cell has granted the underwriters a 30-day option to purchase up to an additional 1,218,750 ordinary shares at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about December 21, 2020, subject to satisfaction of customary closing conditions. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Gamida Cell Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.20 on 12/08/20, with the lowest value was $2.60 for the same time period, recorded on 03/16/20.
Gamida Cell Ltd. (GMDA) full year performance was 70.66%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Gamida Cell Ltd. shares are logging -17.50% during the 52-week period from high price, and 255.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.60 and $11.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 913684 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Gamida Cell Ltd. (GMDA) recorded performance in the market was 96.51%, having the revenues showcasing 96.51% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 431.96M, as it employees total of 79 workers.
Analysts verdict on Gamida Cell Ltd. (GMDA)
During the last month, 7 analysts gave the Gamida Cell Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.42, with a change in the price was noted +5.30. In a similar fashion, Gamida Cell Ltd. posted a movement of +131.19% for the period of last 100 days, recording 402,416 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GMDA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Gamida Cell Ltd. (GMDA): Technical Analysis
Raw Stochastic average of Gamida Cell Ltd. in the period of last 50 days is set at 71.21%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.96%. In the last 20 days, the company’s Stochastic %K was 55.97% and its Stochastic %D was recorded 58.64%.
Let’s take a glance in the erstwhile performances of Gamida Cell Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 96.51%. Additionally, trading for the stock in the period of the last six months notably improved by 77.52%, alongside a boost of 70.66% for the period of the last 12 months. The shares increased approximately by -11.33% in the 7-day charts and went down by 36.29% in the period of the last 30 days. Common stock shares were driven by 96.51% during last recorded quarter.